Literature DB >> 23566531

Successful treatment of extensively drug-resistant Acinetobacter baumannii ventriculitis and meningitis with intraventricular colistin after application of a loading dose: a case series.

Ilias Karaiskos1, Lambrini Galani, Fotini Baziaka, Emmanouela Katsouda, Ioannis Ioannidis, Alexandros Andreou, Harry Paskalis, Helen Giamarellou.   

Abstract

Treatment results of six post-neurosurgical ventriculitis and meningitis cases caused by extensively drug-resistant Acinetobacter baumannii after application of an intraventricular loading dose of 500000 IU (40 mg) of colistin followed by a dose of 125000-250000 IU (10-20 mg) every 24-48 h plus parenteral colistin are reported. Simultaneous bacteraemia with an identical Acinetobacter strain was observed in three patients. The mean duration of treatment was 17.2 days (range 15-21 days) and the median time of sterilisation of cerebrospinal fluid was 2.5 days (range 1-5 days). All patients were cured, however one patient presented with chemical meningitis and one with chemical ventriculitis, conditions that clinically and biochemically resemble bacterial meningitis.
Copyright © 2013 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23566531     DOI: 10.1016/j.ijantimicag.2013.02.010

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  16 in total

1.  Local complications of adjunct intrathecal antibiotics for nosocomial meningitis associated with gram-negative pathogens: a meta-analysis.

Authors:  Alexandros G Brotis; Isaac Churis; Marios Karvouniaris
Journal:  Neurosurg Rev       Date:  2019-12-24       Impact factor: 3.042

Review 2.  Intrathecal/intraventricular colistin in external ventricular device-related infections by multi-drug resistant Gram negative bacteria: case reports and review.

Authors:  O Bargiacchi; A Rossati; P Car; D Brustia; R Brondolo; F Rosa; P L Garavelli; F G De Rosa
Journal:  Infection       Date:  2014-04-12       Impact factor: 3.553

3.  The transcriptomic response of Acinetobacter baumannii to colistin and doripenem alone and in combination in an in vitro pharmacokinetics/pharmacodynamics model.

Authors:  Rebekah Henry; Bethany Crane; David Powell; Deanna Deveson Lucas; Zhifeng Li; Jesús Aranda; Paul Harrison; Roger L Nation; Ben Adler; Marina Harper; John D Boyce; Jian Li
Journal:  J Antimicrob Chemother       Date:  2015-01-14       Impact factor: 5.790

4.  Task force on management and prevention of Acinetobacter baumannii infections in the ICU.

Authors:  José Garnacho-Montero; George Dimopoulos; Garyphallia Poulakou; Murat Akova; José Miguel Cisneros; Jan De Waele; Nicola Petrosillo; Harald Seifert; Jean François Timsit; Jordi Vila; Jean-Ralph Zahar; Matteo Bassetti
Journal:  Intensive Care Med       Date:  2015-10-05       Impact factor: 17.440

Review 5.  Intrathecal Antibacterial and Antifungal Therapies.

Authors:  Roland Nau; Claudia Blei; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2020-04-29       Impact factor: 26.132

6.  Minocycline attenuates colistin-induced neurotoxicity via suppression of apoptosis, mitochondrial dysfunction and oxidative stress.

Authors:  Chongshan Dai; Giuseppe D Ciccotosto; Roberto Cappai; Yang Wang; Shusheng Tang; Xilong Xiao; Tony Velkov
Journal:  J Antimicrob Chemother       Date:  2017-06-01       Impact factor: 5.790

Review 7.  Rescuing the Last-Line Polymyxins: Achievements and Challenges.

Authors:  Sue C Nang; Mohammad A K Azad; Tony Velkov; Qi Tony Zhou; Jian Li
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

8.  Post-neurosurgical meningitis caused by acinetobacter baumannii: case series and review of the literature.

Authors:  Shunlan Ni; Shanshan Li; Naibin Yang; Sainan Zhang; Danping Hu; Qian Li; Mingqin Lu
Journal:  Int J Clin Exp Med       Date:  2015-11-15

9.  Place of Colistin-Rifampicin Association in the Treatment of Multidrug-Resistant Acinetobacter Baumannii Meningitis: A Case Study.

Authors:  Dahraoui Souhail; Belefquih Bouchra; Badia Belarj; Rar Laila; Frikh Mohammed; Oumarou Mamane Nassirou; Ibrahimi Azeddine; Charki Haimeur; Abdelhay Lemnouer; Mostafa Elouennass
Journal:  Case Rep Infect Dis       Date:  2016-03-15

10.  Management of Meningitis Caused by Multi Drug-Resistant Acinetobacter Baumannii: Clinical, Microbiological and Pharmacokinetic Results in a Patient Treated with Colistin Methanesulfonate.

Authors:  Elisabetta Schiaroli; Maria Bruna Pasticci; Maria Iris Cassetta; Stefania Fallani; Corrado Castrioto; Matteo Pirro; Andrea Novelli; Lucia Henrici De Angelis; Marco Maria D'Andrea; Maria Lina Mezzatesta; Franco Baldelli; Antonella Mencacci
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-10-11       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.